PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes

Lung Cancer

First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis

J Thorac Oncol

Brunetti L, Colella G, Di Fazio GR, La Cava G, Santo V, Pecci F, Rotow J, Bauman JR, Nassar AH, Adib E, Naqash AR, Tagliamento M, Ferrara R, Citarella F, Russano M, Ricciuti B, Faivre-Finn C, Hendriks LEL, Passaro A, Vincenzi B, Acker F, Derosa L, Planchard D, Aerts HJWL, Novello S, Passiglia F, Greco C, Ramella S, Cortellini A

doi: 10.1016/j.jtho.2026.103735

Lung Cancer

Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy

Clin Lung Cancer

Fortman D, Wang H, VanderWeele R, Evans T, Herman JG, Rhee J, Reyes V, McLaughlin B, Wozniak A, Somasundaram A, Mekhail T, Socinski MA, Schulze K, Villaruz LC

doi: 10.1016/j.cllc.2024.10.014

Lung Cancer

Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco

Clin Cancer Res

Gariazzo E, Elkrief A, Concannon K, Ognissanti D, Dodi A, Favorito V, Di Federico A, De Giglio A, Brunetti L, Santo V, Pecci F, Aldea M, Garbo E, Alessi JV, LoPiccolo J, Paoloni F, Nishino M, Sholl LM, Florez N, Rotow J, Frumm SM, Hong L, Zhang J, Gibbons D, Wang X, Landi L, Cipriani L, Rakaee M, Cortellini A, Tiseo M, Cappuzzo F, Ardizzoni A, Awad MM, Heymach JV, Scalera S, Maugeri-Saccà M, Metro G, Vokes N, Schoenfeld A, Ricciuti B

doi: 10.1158/1078-0432.CCR-25-4793

RECOMMENDED

Lung Cancer

Comparative efficacy and safety of post-TKI treatments for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and network meta-analysis

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lung Cancer

Wang Y, Zhang L, Zhan J, Wen L, Zhao X, Sun H, Chen X, Zhang Y, Chen G, Zhao Y, Huang Y, Fang W, Zhang L, Sun D, Yang Y

doi: 10.1016/j.lungcan.2026.108914

Lung Cancer

Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis

Semin Oncol

Ganatra N, Thompson J, Desai R, Doshi J, Jain P, Pasnoor DS, Jain A

doi: 10.1016/j.seminoncol.2025.152431

RECOMMENDED

AsthmaRespiratory Tract Infection

Efficacy of biologic agents in patients with comorbid asthma and chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Eur Respir Rev

Kyriakopoulos C, Ntritsos G, Gogali A, Papanikolaou A, Angelopoulos V, Oikonomou ED, Kostikas K

doi: 10.1183/16000617.0186-2025

Lung Cancer

PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial

Nat Commun

Zeng L, Ruan Z, Yan H, Qin H, Zeng Z, Zou C, Huang Z, Jiang W, Dai J, Xu S, Song L, Chen Y, Zhang Y, Zeng F, Wei S, Chen S, Liu L, Xiong Y, Wang Z, Deng J, Zhang X, Sun Y, Yang D, Zhou C, Yang H, Li Y, Deng L, Xu Q, Fang C, Chen X, Wang J, Li T, Zhang G, Zhou H, Yang N, Zhang Y

doi: 10.1038/s41467-025-67262-x

COPD

Non-Pharmacological Interventions for Fatigue in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review and Network Meta-Analysis

Respir Med

Zhang X, Xue J, Chang Y, Zhang R, Zhao J, Li X, Lu H, Jiang X, Yu F, Yang P

doi: 10.1016/j.rmed.2025.108409

Sleep Apnea

The efficacy and safety of an intraoral negative air pressure device in patients with obstructive sleep apnea: a systematic review and meta-analysis

J Clin Sleep Med

Puvatanond C, Kasemsuk N, Banhiran W

doi: 10.5664/jcsm.11812

Related content

First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis

Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy

Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco

Comparative efficacy and safety of post-TKI treatments for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and network meta-analysis

Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis

Efficacy of biologic agents in patients with comorbid asthma and chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials

PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial

Non-Pharmacological Interventions for Fatigue in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review and Network Meta-Analysis

The efficacy and safety of an intraoral negative air pressure device in patients with obstructive sleep apnea: a systematic review and meta-analysis